Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 9 Similar Profiles
Cancer Vaccines Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Granulocyte-Macrophage Colony-Stimulating Factor Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Vaccines Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1992 2018

Breast cancer immunotherapy: Facts and hopes

Emens, L. A. Feb 1 2018 In : Clinical Cancer Research. 24, 3, p. 511-520 10 p.

Research output: Contribution to journalReview article

Immunotherapy
Breast Neoplasms
CD274 Antigen
Biomarkers
Triple Negative Breast Neoplasms

Racial disparities in the rate of cardiotoxicity of HER2-targeted therapies among women with early breast cancer

Litvak, A., Batukbhai, B., Russell, S. D., Tsai, H. L., Rosner, G. L., Jeter, S. C., Armstrong, D., Emens, L. A., Fetting, J., Wolff, A. C., Silhy, R., Stearns, V. & Connolly, R. M. Jan 1 2018 (Accepted/In press) In : Cancer.

Research output: Contribution to journalArticle

Breast Neoplasms
Therapeutics
Confidence Intervals
Stroke Volume
Incidence
Tumor Microenvironment
Macrophages
Neoplasms
Ovarian epithelial cancer
Recurrence

A STING Agonist Given with OX40 Receptor and PD-L1 Modulators Primes Immunity and Reduces Tumor Growth in Tolerized Mice

Foote, J. B., Kok, M., Leatherman, J. M., Armstrong, T. D., Marcinkowski, B. C., Ojalvo, L. S., Kanne, D. B., Jaffee, E. M., Dubensky, T. W. & Emens, L. A. Jun 1 2017 In : Cancer Immunology Research. 5, 6, p. 468-479 12 p.

Research output: Contribution to journalArticle

OX40 Receptor
Interferons
Immunity
T-Lymphocytes
Growth

Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study

Dirix, L. Y., Takacs, I., Jerusalem, G., Nikolinakos, P., Arkenau, H. T., Forero-Torres, A., Boccia, R., Lippman, M. E., Somer, R., Smakal, M., Emens, L. A., Hrinczenko, B., Edenfield, W., Gurtler, J., von Heydebreck, A., Grote, H. J., Chin, K. & Hamilton, E. P. Oct 23 2017 (Accepted/In press) In : Breast Cancer Research and Treatment. p. 1-16 16 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Antibodies
Triple Negative Breast Neoplasms
Neoplasms
Therapeutics